Search
Skip to Search Results- 1Chen, Christopher B
- 1Kang, Dong-Woo
- 1Khodayari Moez, Elham
- 1Lamey, Michael
- 1Miklavcic, John
- 1Pervez, Nadeem
- 1Andrew, Jeffery (University of British Columbia Okanagan)
- 1Clandinin, M Tom (Agricultural, Food and Nutritional Science)
- 1Courneya, Kerry (Kinesiology, Sport, and Recreation)
- 1Dinu, Irina (School of Public Health)
- 1Dr. Gino Fallone, Physics\Oncology, University of Alberta
- 1Dr. Nicola De Zanche, Oncology, University of Alberta
-
Ganglioside Increases Metastatic Potential and Susceptibility of Prostate Cancer to Gene Therapy in vitro
DownloadFall 2009
Prostate cancer (CaP) is the 2nd most common cancer in North American men. Tumour management strategies are appropriate for early stage disease, but advanced disease has a poor prognosis and requires prompt treatment. Therefore, research into delay of tumour progression and efficacious treatment...
-
Impact of conventional fractionated RT to pelvic lymph nodes and dose-escalated hypofractionated RT to prostate gland using IMRT treatment delivery in high-risk prostate cancer
DownloadFall 2009
Prostate cancer is the most common cancer among Canadian men. The standard treatment in high-risk category is radical radiation, with androgen suppression treatment (AST). Significant disease progression is reported despite this approach. Radiation dose escalation has been shown to improve...
-
Spring 2010
A prototype system which has integrated a linear accelerator (linac) with a magnetic resonance imager (MRI) has been constructed at the Cross Cancer Institute. The real time operation of a linac-MRI system will require proper radio frequency (RF) shielding such that the MRI images can be acquired...
-
Fall 2016
Relative to those without diabetes, individuals with type 2 diabetes have an increased risk of several cancers, but a decreased risk of prostate cancer. While metformin may reduce the risk of some cancers, it may not reduce the risk of prostate cancer. However, race/ethnicity may modify...
-
Fall 2018
Human genomic data are being generated at an increasing rate owing to the advancement of high-throughput technology. Wider availability of genomics, transcriptomics, proteomics and metabolomics data motivated complex study questions with the intention to gain higher degree of understanding of...
-
Guiding treatment selection for advanced prostate cancer with biogenic silver nanoparticles
DownloadFall 2018
Prostate cancer (PCa) is the second most common cancer in men worldwide. Men with advanced PCa often face poor prognosis and are at high risk for mortality. To improve prognosis in this high risk population, targeting a reliable biological factor or marker that predicts a patient’s response...
-
Spring 2021
Background: Prostate cancer treatments often lead to side effects including sexual and urinary dysfunction as well as fatigue and poor quality of life. As a means of avoiding these side effects, active surveillance has been introduced as a strategy to manage men with low- to moderate-grade...